Financhill
Back

Cadence Design Systems Vs. Collegium Pharmaceutical Industry Stock Comparison

Buy
53

CDNS
Cadence Design Systems

Last Price:
$302.67
Seasonality Move:
3.98%
Sell
45

COLL
Collegium Pharmaceutical

Last Price:
$33.33
Seasonality Move:
-1.63%
Buy
53
Cadence Design Systems (CDNS) is a Buy

Is Cadence Design Systems a Buy, Sell or Hold?

  • The current Cadence Design Systems [CDNS] share price is $302.73. The Score for CDNS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • CDNS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Collegium Pharmaceutical (COLL) is a Sell

Is Collegium Pharmaceutical a Buy, Sell or Hold?

  • The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CDNS Stock Price Chart

What is Cadence Design Systems's stock price today?

  • The Cadence Design Systems share price today is $302.73
    The current trend is moderately bearish and CDNS is experiencing selling pressure, which indicates risk of future bearish movement.

COLL Stock Price Chart

What is Collegium Pharmaceutical's stock price today?

  • The Collegium Pharmaceutical share price today is $33.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.

CDNS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.22 Buy
Relative Strength Index (14 RSI): 49.35 Sell
Chaikin Money Flow: -496245 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (300.66 - 311.82) Sell
Bollinger Bands (100): (264.96 - 304.66) Buy

COLL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 66.05 Buy
Chaikin Money Flow: 1007158 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.9 - 30.94) Buy
Bollinger Bands (100): (30.52 - 37.92) Sell

CDNS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 302.68 Buy
20-day SMA: 304.86 Sell
50-day SMA: 301.61 Buy
200-day SMA: 288.9 Buy
8-day EMA: 303.37 Sell
20-day EMA: 304.05 Sell
50-day EMA: 299.11 Buy
200-day EMA: 285.83 Buy

COLL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.45 Buy
20-day SMA: 29.79 Buy
50-day SMA: 30.91 Buy
200-day SMA: 34.47 Sell
8-day EMA: 30.02 Buy
20-day EMA: 29.94 Buy
50-day EMA: 31.21 Buy
200-day EMA: 32.94 Buy

Cadence Design Systems Earnings Growth & CDNS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and an increase next year of $1.01 per share.

Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.

Cadence Design Systems Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Collegium Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):